View Older Stories View More Recent Stories

Mar 20, 2026 09:34AM VivoPower converts 2.96 million shares to reduce public float
Mar 20, 2026 09:32AM VivoPower Commences Strategic Share Conversion Program; Initial 2.96 Million Listed Class A Ordinary Shares Becoming Unlisted Restricted Class B Shares, Reducing Public Float
Mar 19, 2026 04:01PM SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
Mar 19, 2026 08:15AM CORVEX ANNOUNCES CLOSING OF ALL-STOCK MERGER
Mar 17, 2026 10:46PM SAB Biotherapeutics prices $85 million public offering at $3.85 per share
Mar 17, 2026 10:46PM SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
Mar 17, 2026 04:01PM SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Mar 17, 2026 07:49AM Chardan Downgrades Urgent.ly (ULY) to Neutral
Mar 12, 2026 03:17PM Chardan Reiterates Buy Rating on Orchestra BioMed Inc. (OBIO): "warrants a new look by investors"
Mar 9, 2026 01:04PM uniQure BV (QURE) PT Raised to $31 at Chardan
Mar 4, 2026 02:56PM EyePoint Inc. (EYPT) PT Raised to $29 at Chardan
Mar 4, 2026 09:21AM Chardan Reiterates Buy Rating on Arbutus Biopharma (ABUS) Following Moderna Settlement
Mar 2, 2026 05:37PM Chardan Reiterates Buy Rating on Dyne Therapeutics (DYN)
Mar 2, 2026 02:18PM Intellia Therapeutics (NTLA) PT Raised to $27 at Chardan
Feb 25, 2026 07:00AM TheSportExchange Announces Intent to Pursue NASDAQ Direct Listing
Feb 24, 2026 07:39AM Chardan Capital Markets Upgrades Allurion Technologies (ALUR) to Buy
Feb 12, 2026 08:30AM United Acquisition Corp. I Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 18, 2026
Feb 2, 2026 09:15AM VivoPower terminates at-the-market equity offering agreement
Feb 2, 2026 09:15AM VivoPower International PLC Announces Termination of At-the-Market (ATM) Equity Offering Agreement
Jan 30, 2026 05:25PM United Acquisition Corp. I Announces Closing of $100,000,000 Million Initial Public Offering
Jan 29, 2026 12:34AM Chardan Capital Markets Upgrades Korro Bio Inc. (KRRO) to Buy
Jan 28, 2026 07:15PM United Acquisition Corp. I Announces Pricing of $100 Million Initial Public Offering
Jan 26, 2026 11:02AM Black Spade Acquisition III Co Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing January 29, 2026
Jan 23, 2026 06:44PM Aldabra 4 completes $300.15 million IPO on NASDAQ
Jan 23, 2026 06:44PM Aldabra 4 Liquidity Opportunity Vehicle, Inc. Announces Closing of $300.15 Million Initial Public Offering
Jan 21, 2026 08:25PM Aldabra 4 prices $261 million IPO at $10 per unit
Jan 21, 2026 08:25PM Aldabra 4 Liquidity Opportunity Vehicle, Inc. Announces Pricing of $261 Million Initial Public Offering
Jan 21, 2026 04:15AM Chardan Capital Markets Starts Alumis Inc (ALMS) at Buy
Jan 20, 2026 09:00AM ZOOZ Reports Preliminary 2025 Financial Information, Cash and Bitcoin Positions and Additional Corporate Updates
Jan 20, 2026 07:27AM Chardan Capital Markets Starts ZOOZ Strategy (ZOOZ) at Buy
Jan 7, 2026 02:00PM Black Spade Acquisition III closes $172.5 million IPO on NYSE
Jan 7, 2026 02:00PM Black Spade Acquisition III Co Announces Closing of $172.5 Million Initial Public Offering, Including Full-Exercise of Over-Allotment Option
Jan 5, 2026 06:09PM Black Spade Acquisition III prices $150 million IPO
Jan 5, 2026 06:09PM Black Spade Acquisition III Co Announces Pricing of $150 Million Initial Public Offering
Jan 5, 2026 07:29AM Chardan Capital Markets Assumes Alto Neuroscience (ANRO) at Buy
Jan 5, 2026 04:35AM Chardan Capital Markets Assumes Reviva Pharmaceuticals (RVPH) at Buy
Jan 5, 2026 04:34AM Chardan Capital Markets Assumes Stoke Therapeutics (STOK) at Buy
Dec 31, 2025 04:09PM QumulusAI files for direct listing on Nasdaq
Dec 24, 2025 06:00AM Chardan Capital Markets Starts Hyperliquid Strategies, Inc. (PURR) at Buy
Dec 24, 2025 05:59AM Chardan Capital Markets Starts Hyperion DeFi, Inc. (HYPD) at Buy
Dec 23, 2025 04:42AM Chardan Capital Markets Starts Kalaris (KLRS) at Buy
Dec 23, 2025 04:41AM Chardan Capital Markets Starts Annexon Biosciences (ANNX) at Buy
Dec 18, 2025 01:17PM AB Science announces the initiation of coverage of its stock by Maxim Group with a target price of EUR 4.0 per share
Dec 16, 2025 03:50AM Palvella Therapeutics (PVLA) PT Raised to $174 at Chardan Capital Markets
Dec 4, 2025 09:00AM Lion Group raises $10 million, allocates $8 million for bitcoin purchase
Dec 4, 2025 09:00AM Lion Group Holding Ltd Announces $10 Million Private Placement for the acquisition of Bitcoin (BTC)
Dec 2, 2025 04:31PM Hyperliquid Strategies completes business combination with Sonnet BioTherapeutics
Dec 2, 2025 04:30PM Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Nov 13, 2025 04:30PM Senti Bio reports Q3 financial results, confirms ASH data presentation
Nov 13, 2025 04:30PM Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual
View More Recent Stories View Older Stories